These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24401005)

  • 1. Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study.
    Kennish L; Attur M; Oh C; Krasnokutsky S; Samuels J; Greenberg JD; Huang X; Abramson SB
    BMC Musculoskelet Disord; 2014 Jan; 15():8. PubMed ID: 24401005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferritin concentrations in synovial fluid are higher in osteoarthritis patients with HFE gene mutations (C282Y or H63D).
    Carroll GJ; Sharma G; Upadhyay A; Jazayeri JA
    Scand J Rheumatol; 2010; 39(5):413-20. PubMed ID: 20560808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of heterozygous hemochromatosis C282Y gene mutation with hand osteoarthritis.
    Ross JM; Kowalchuk RM; Shaulinsky J; Ross L; Ryan D; Phatak PD
    J Rheumatol; 2003 Jan; 30(1):121-5. PubMed ID: 12508400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
    World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary osteoarthritis in the ankle joint is associated with finger metacarpophalangeal osteoarthritis and the H63D mutation in the HFE gene: evidence for a hemochromatosis-like polyarticular osteoarthritis phenotype.
    Carroll GJ
    J Clin Rheumatol; 2006 Jun; 12(3):109-13. PubMed ID: 16755236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.
    Chan AT; Ma J; Tranah GJ; Giovannucci EL; Rifai N; Hunter DJ; Fuchs CS
    J Natl Cancer Inst; 2005 Jun; 97(12):917-26. PubMed ID: 15956653
    [TBL] [Abstract][Full Text] [Related]  

  • 10.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
    Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene.
    Koziol JA; Ho NJ; Felitti VJ; Beutler E
    Clin Chem; 2001 Oct; 47(10):1804-10. PubMed ID: 11568090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
    Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
    J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.
    Gurrin LC; Bertalli NA; Dalton GW; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Nicoll AJ; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
    Hepatology; 2009 Jul; 50(1):94-101. PubMed ID: 19554541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The common HFE variants C282Y and H63D are not associated with primary OA of the hip or knee.
    Loughlin J; Carr A; Chapman K
    J Rheumatol; 2005 Feb; 32(2):391-2; author reply 392. PubMed ID: 15693075
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center.
    Waalen J; Felitti V; Gelbart T; Ho NJ; Beutler E
    Am J Med; 2002 Oct; 113(6):472-9. PubMed ID: 12427496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the HFE hemochromatosis gene in a community-based population of elderly women.
    Rossi E; Kuek C; Beilby JP; Jeffrey GP; Devine A; Prince RL
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1150-4. PubMed ID: 15377292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.